Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TVINGSTRUP DYREKLINIK A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.6% 2.0% 5.0% 2.0% 1.3% 1.5% 13.0% 13.0%   Credit score (0-100)   63 70 44 67 79 75 18 18   Credit rating   BBB A BBB A A A BB BB   Credit limit (kDKK)   0.0 0.4 0.0 0.5 58.3 18.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,374 5,203 4,626 5,262 5,470 6,730 0.0 0.0   EBITDA   231 370 169 1,378 1,062 789 0.0 0.0   EBIT   50.1 212 -1.7 1,244 904 661 0.0 0.0   Pre-tax profit (PTP)   60.9 228.3 9.8 1,241.4 886.4 664.2 0.0 0.0   Net earnings   46.6 178.7 7.3 968.1 688.4 518.5 0.0 0.0   Pre-tax profit without non-rec. items   60.9 228 9.8 1,241 886 664 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   460 548 320 467 368 311 0.0 0.0   Shareholders equity total   1,439 1,618 609 1,577 2,029 2,027 1,027 1,027   Interest-bearing liabilities   14.4 14.4 852 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,841 3,250 3,266 3,492 3,415 3,465 1,027 1,027   Net Debt   -1,212 -1,455 -919 -1,763 -1,970 -1,874 -1,027 -1,027     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,374 5,203 4,626 5,262 5,470 6,730 0.0 0.0   Gross profit growth   -1.2% 19.0% -11.1% 13.7% 3.9% 23.0% -100.0% 0.0%   Employees   10 10 10 11 11 13 0 0   Employee growth %   0.0% 0.0% 0.0% 10.0% 0.0% 18.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,841 3,250 3,266 3,492 3,415 3,465 1,027 1,027   Balance sheet change%   19.8% 14.4% 0.5% 6.9% -2.2% 1.5% -70.4% 0.0%   Added value   231.4 370.1 169.0 1,377.8 1,038.1 789.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -314 -71 -398 12 -256 -185 -311 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   1.1% 4.1% -0.0% 23.6% 16.5% 9.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   2.6% 7.5% 0.3% 37.1% 26.3% 19.3% 0.0% 0.0%   ROI %   4.4% 14.4% 0.7% 82.5% 50.4% 32.7% 0.0% 0.0%   ROE %   3.1% 11.7% 0.7% 88.6% 38.2% 25.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   50.7% 49.8% 18.7% 45.2% 59.4% 58.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -524.0% -393.1% -544.1% -128.0% -185.5% -237.5% 0.0% 0.0%   Gearing %   1.0% 0.9% 139.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   23.5% 0.4% 0.2% 2.7% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.3 1.3 0.9 1.2 1.7 1.8 0.0 0.0   Current Ratio   1.7 1.8 1.1 1.6 2.2 2.2 0.0 0.0   Cash and cash equivalent   1,226.7 1,469.4 1,771.8 1,762.9 1,969.7 1,874.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   978.9 1,141.2 263.9 1,085.6 1,636.0 1,691.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   23 37 17 125 94 61 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   23 37 17 125 97 61 0 0   EBIT / employee   5 21 -0 113 82 51 0 0   Net earnings / employee   5 18 1 88 63 40 0 0